The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-benzyl-3-(5-bromopentyloxy)-5-nitro-1H-indazole ID: ALA4743080
PubChem CID: 162647185
Max Phase: Preclinical
Molecular Formula: C19H20BrN3O3
Molecular Weight: 418.29
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=[N+]([O-])c1ccc2c(c1)c(OCCCCCBr)nn2Cc1ccccc1
Standard InChI: InChI=1S/C19H20BrN3O3/c20-11-5-2-6-12-26-19-17-13-16(23(24)25)9-10-18(17)22(21-19)14-15-7-3-1-4-8-15/h1,3-4,7-10,13H,2,5-6,11-12,14H2
Standard InChI Key: HYAIGRYNUQZUJT-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
15.8737 -17.0079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3552 -19.0195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9245 -19.0201 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.0086 -22.8931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2877 -21.4971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6252 -17.7930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8199 -17.9668 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.1965 -22.7265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6371 -17.7832 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.5752 -20.0969 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.9347 -21.9433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5500 -22.2746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6373 -18.6076 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.4838 -21.3262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0673 -20.2590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8372 -20.8791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5672 -18.7561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0602 -19.4236 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.6790 -16.8299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0654 -18.6069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7843 -19.8464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7792 -19.0159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3540 -19.8463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9276 -16.0433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7332 -15.8653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9817 -15.0787 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
17 22 1 0
6 1 1 0
17 7 1 0
7 6 1 0
4 12 2 0
20 2 1 0
12 5 1 0
10 16 1 0
2 13 1 0
22 20 2 0
1 19 1 0
21 10 1 0
15 21 2 0
11 8 2 0
13 9 1 0
22 21 1 0
16 5 1 0
2 23 2 0
5 14 2 0
8 4 1 0
10 18 1 0
18 17 2 0
23 15 1 0
13 3 2 0
14 11 1 0
19 24 1 0
24 25 1 0
25 26 1 0
M CHG 2 9 -1 13 1
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 418.29Molecular Weight (Monoisotopic): 417.0688AlogP: 4.94#Rotatable Bonds: 9Polar Surface Area: 70.19Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 5.39CX LogD: 5.39Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.21Np Likeness Score: -1.40
References 1. Ibáñez-Escribano A,Reviriego F,Vela N,Fonseca-Berzal C,Nogal-Ruiz JJ,Arán VJ,Escario JA,Gómez-Barrio A. (2021) Promising hit compounds against resistant trichomoniasis: Synthesis and antiparasitic activity of 3-(ω-aminoalkoxy)-1-benzyl-5-nitroindazoles., 37 [PMID:33556576 ] [10.1016/j.bmcl.2021.127843 ]